Apokyn) and would place it in a non-preferred branded tier without restrictions in commercial and Medicare plans.
Britannia will supply
Apokyn to patients through US-based USWorldMeds, which will offer the drug in the US as of December, Ipsen said on Thursday.
An alternative to
Apokyn in approaching the problem of off episodes is rasagiline, a potent once-daily second-generation MAO type-B inhibitor.
An alternative to
Apokyn in approaching the problem of off episodes is rasagiline, a potent once-daily second-generation MAO type-B inhibitor that reduces the frequency of such episodes by blocking dopamine breakdown, although it's not useful as rescue therapy during an episode.
An alternative to
Apokyn in approaching the problem of off episodes is rasagiline, a potent once daily second generation MAO type-B inhibitor that reduces the frequency of such episodes by blocking dopamine breakdown, although it's not useful as rescue therapy during an episode.
"We're proud to partner with Bertek to provide convenient distribution of
Apokyn," asserts Greg Weishar, president and chief executive officer of PharmaCare, a subsidiary of CVS Corp.
